Kathy Dong named CEO of Electra
Plus: Angèle Maki named CBO at Hummingbird and an update from AviadoBio
Kathy Dong became president and CEO at Electra Therapeutics Inc., which is developing antibodies to treat immunological diseases and cancer. Dong was COO of Star Therapeutics Inc., a company that spun out of Electra, and VP of commercial development at True North Therapeutics Inc. She succeeds Adam Rosenthal, who was Electra’s co-founder and CEO and who will serve on the company’s board in addition to his role as Star’s CEO. Electra also appointed Matthew Fust to its board as an independent director and chair of the audit committee.
Hummingbird Bioscience Pte. Ltd. hired Angèle Maki as CBO. Maki was SVP and head of business development at ReCode Therapeutics Inc., and VP, venture science, corporate business development at Eli Lilly and Co. (NYSE:LLY)...